« Previous
Next »
Heart & Lung: The Journal of Acute and Critical Care
Volume 40, Issue 3
, Pages e78-e83
, May 2011
Pregnancy-associated plasma protein predicts outcomes of percutaneous coronary intervention in patients with non–ST-elevation acute coronary syndrome
References
- Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med. 2001;345:1022–1029
- . Levels of pregnancy-associated plasma protein A and insulin-like growth factor-1 in patients with coronary artery disease. Clin Invest Med. 2008;31:E85–E89
- Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J. 2005;26:2093–2098
- Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation. 2004;109:1724–1728
- Circulating pregnancy-associated plasma protein predicts outcome inpatients with acute coronary syndrome but no troponin I elevation. Circulation. 2003;108:1924–1926
- Investigators CS. Pregnancy-associated plasma protein-A levels inpatients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol. 2005;45:229–237
- . Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J. 2002;36:358–361
- Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem. 2000;275:31128–31133
- . Study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. N Engl J Med. 1985;312:932–936
- Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–130
- Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol. 2007;117:365–369
- . Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–372
- . Ligand occupancy of the alfa-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci U S A. 1996;93:2482–2487
- Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem. 2009;42:828–834
- ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006;47:e1–e121
- Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation. 2001;104:992–997
- C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. Am Heart J. 2009;158:277–283
- Association between plasma pregnancy-associated plasma protein A and restenosis after percutaneous coronary angioplasty. Circ J. 2008;72:729–733
This study was supported by a grant from Guangdong Science and Technology Foundation (No. 2008A030201011) and Guangdong Medical Scientific Research Foundation (No. A2008176).
This study followed the local ethics guidelines for human research and was approved by the institutional review board of the First Affiliated Hospital of Sun Yat-Sen University.
PII: S0147-9563(10)00277-3
doi: 10.1016/j.hrtlng.2010.06.006
« Previous
Next »
Heart & Lung: The Journal of Acute and Critical Care
Volume 40, Issue 3
, Pages e78-e83
, May 2011
